Lingyu Wei
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Viral-associated cancers and disorders
Papers in
-
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 3
- S100 Proteins and Annexins 2
- Immunology 11
- Immune cells in cancer 5
- Co-authors
- Jian Ma (14 shared papers)Jinjin Chen (2 shared papers)Jianxun Ding (2 shared papers)Peng Qiu (12 shared papers)Xiang Zheng (11 shared papers)Qun Yan (12 shared papers)Guiyuan Li (7 shared papers)Zailong Qin (6 shared papers)
- Journals
- Journal of Virology (2 papers)Acta Biomaterialia (2 papers)Journal of Biological Chemistry (2 papers)Cell Death and Disease (2 papers)Frontiers in Pharmacology (1 paper)
- Partner nations
- ChinaSaudi ArabiaEthiopia
In The Last Decade
Lingyu Wei
30 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 231
- Oncology 254
- Biomaterials 136
- Molecular Medicine 45
- Immunology 172
Countries citing papers authored by Lingyu Wei
This map shows the geographic impact of Lingyu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyu Wei more than expected).
Fields of papers citing papers by Lingyu Wei
This network shows the impact of papers produced by Lingyu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyu Wei. The network helps show where Lingyu Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyu Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 111 | |
| 2 | 2017 | 103 | |
| 3 | 2018 | 86 | |
| 4 | 2017 | 77 | |
| 5 | 2022 | 74 | |
| 6 | 2020 | 66 | |
| 7 | 2023 | 61 | |
| 8 | 2021 | 57 | |
| 9 | 2016 | 55 | |
| 10 | 2019 | 47 | |
| 11 | 2018 | 42 | |
| 12 | 2020 | 35 | |
| 13 | 2021 | 34 | |
| 14 | 2019 | 23 | |
| 15 | 2021 | 18 | |
| 16 | 2021 | 18 | |
| 17 | 2020 | 18 | |
| 18 | 2020 | 15 | |
| 19 | 2024 | 14 | |
| 20 | 2020 | 11 |
About Lingyu Wei
Lingyu Wei is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Viral-associated cancers and disorders (5 papers), Immune cells in cancer (5 papers), Infant Nutrition and Health (3 papers), Epigenetics and DNA Methylation (3 papers), Neonatal Respiratory Health Research (3 papers), Cancer-related molecular mechanisms research (3 papers) and S100 Proteins and Annexins (2 papers). The work is most often cited by research in Cancer Research (231 citations), Oncology (254 citations), Biomaterials (136 citations), Molecular Medicine (45 citations) and Immunology (172 citations). Lingyu Wei has collaborated with scholars based in China, Saudi Arabia and Ethiopia. Frequent co-authors include Jian Ma, Jinjin Chen, Jianxun Ding, Peng Qiu, Xiang Zheng, Qun Yan, Guiyuan Li, Zailong Qin, Zhengshuo Li and Yuanjun Lu. Their work appears in journals such as Journal of Virology, Acta Biomaterialia, Journal of Biological Chemistry, Cell Death and Disease and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.